Experience innovations of the future

ZEISS QUALITY INNOVATIONS WORLDWIDE event in Oberkochen, Germany, January 20-21, 2026.

ZEISS EVO as the Key to Wire Technology in Modern Medicine

High-performance wires for stents.

New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Stockholm (2025)

FDA’s Top Vaccine Official resigns – Issues sharp criticism of Kennedy

FDA’s Top Vaccine Official is leaving his post while simultaneously criticizing the country’s health secretary for allowing “misinformation and lies” to influen...

Shaping the Future of Metrology – Live in Your Region

Insights into our event series.

GU Ventures AB

Moderna lägger ner vaccinprojekt – ska minska FoU-investeringar

Vaccinutvecklaren Moderna lägger ner ytterligare tre av sina mRNA-program.

CDC avslutar all forskning på apor

Den amerikanska smittskyddsmyndigheten CDC har informerat sina forskare om att all forskning på apor ska avvecklas innan årets slut.

Sneak Peek of ZEISS Metrology Expert Tips Season 2

The second season of the video series starts in January 2026, but you can discover more about the highlights of Season 2 now.

Folkmedicin från 1700-talet kan bli modern cancerkur

En huskur från 1700-talet blev med tiden ett läkemedel mot hjärtsvikt. Nu ska forskare i Skövde pröva om digitoxin kan ha ytterligare ett användningsområde – so...

Novo Nordisk cuts ties with Hims & Hers after Wegovy dispute

Novo Nordisk is ending its collaboration with Hims & Hers Health due to concerns about the company’s sales and marketing practices related to the weight-loss drug Wegovy.

The future of healthcare in focus: ”Together, things happen”

In march, it’s once again time for Fokus Patient, an event for the industry where the patients’ perspective takes center stage. It’s a great way to spread knowl...

We desire talent to come here, but are we genuinely welcoming them?

Sweden faces significant challenges in creating a truly inclusive environment that makes international professionals feel welcome, valued, and able to build mea...

Novo Nordisk tells staff to return to office

At the turn of the year, Novo Nordisk employees will no longer be able to work remotely. According to the company’s new CEO, the move is intended to accelerate ...

The Future of Metrology is Coming to Your Region

Join our event series.

”Trickier than bacteria”: Why severe fungal infections are on the rise

There’s a reason Earth is sometimes called the planet of fungi. These ancient organisms – billions of years old and more closely related to animals than to plan...

Shaping regulatory complexity into strategic clarity

As AI continues to reshape healthcare, clear guidance on health data use is more critical than ever. Building on the success of the AI Act e-tool and the Data A...

Novo Nordisk kapar banden med Hims & Hers efter Wegovy-strid

Novo Nordisk avslutar samarbetet med Hims & Hers Health. Anledningen är oro kring företagets försäljning och marknadsföring av viktläkemedlet Wegovy.

Eli Lilly slår alla rekord – börsvärdet uppe i 1 000 000 000 000 dollar

För första gången har ett läkemedelsbolag nått svindlande 1 biljon dollar i börsvärde. Det är amerikanska Eli Lilly som tack vare enorma framgångar inom framför...

Many discontinue obesity medication – new study highlights the reasons

A new study maps out the most common reasons why patients choose to stop taking obesity medication prematurely. “Obesity medication discontinuation reverses hea...

ZEN core now available for all ZEISS scanning electron microscopes

Introducing intuitive, streamlined SEM control over imaging, analytics, and multi-modal workflows.

Scientific Solutions

Who pays for Rebecca Doe – and all of us?

Anna Törner on how easily we get used to the idea that healthcare is free - when it really is about how and who pays for it

Southern Swedish company Aqilion develops drug for eosinophilic esophagitis

When Aqilion began developing a drug for eosinophilic esophagitis, the molecule was classified as an orphan drug. But the prevalence of the disease now appears ...